Patrick B Donnelly
Stock Analyst at Citi
(4.35)
# 1,304
Out of 5,065 analysts
576
Total ratings
54.7%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $300 → $480 | $399.42 | +20.17% | 4 | Oct 6, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $185 → $190 | $169.90 | +11.83% | 38 | Aug 27, 2026 | |
| BRKR Bruker | Reiterated: Hold | $60 → $53 | $55.37 | -4.28% | 31 | Aug 5, 2026 | |
| ILMN Illumina | Reiterated: Sell | $95 → $113 | $262.66 | -56.98% | 44 | Aug 3, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | $22 | $22.42 | -1.87% | 14 | Jul 31, 2026 | |
| DHR Danaher | Reiterated: Buy | $230 | $224.43 | +2.48% | 31 | Jul 22, 2026 | |
| AVTR Avantor | Reiterated: Hold | $9 → $11 | $16.29 | -32.47% | 24 | Jul 8, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $265 | $300.02 | -11.67% | 24 | Jul 8, 2026 | |
| GH Guardant Health | Reiterated: Buy | $150 → $215 | $157.88 | +36.18% | 23 | Jul 8, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Buy | $1,550 | $1,625.73 | -4.66% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $18 | $12.76 | +41.07% | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $45 | $69.89 | -35.61% | 27 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $70 → $73 | $72.49 | +0.70% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $120 → $140 | $168.18 | -16.76% | 19 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $17.64 | +30.39% | 13 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $28 | $30.71 | -8.82% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $55 | $35.19 | +56.29% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $38 | $46.55 | -18.37% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 → $400 | $383.91 | +4.19% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $352.82 | -14.97% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $265.88 | -24.78% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $19.02 | +36.70% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $434.27 | -2.13% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $685 | $679.38 | +0.83% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 | $234.91 | -8.48% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 | $318.83 | +1.94% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $150.94 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $6 | $3.68 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $4.25 | $2.03 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $24.19 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $15.88 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $36 | $23.95 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $4.21 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 | $0.0007 | n/a | 1 | Nov 30, 2018 |
Natera
Oct 6, 2026
Reiterated: Buy
Price Target: $300 → $480
Current: $399.42
Upside: +20.17%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $185 → $190
Current: $169.90
Upside: +11.83%
Bruker
Aug 5, 2026
Reiterated: Hold
Price Target: $60 → $53
Current: $55.37
Upside: -4.28%
Illumina
Aug 3, 2026
Reiterated: Sell
Price Target: $95 → $113
Current: $262.66
Upside: -56.98%
Fortrea Holdings
Jul 31, 2026
Reiterated: Buy
Price Target: $22
Current: $22.42
Upside: -1.87%
Danaher
Jul 22, 2026
Reiterated: Buy
Price Target: $230
Current: $224.43
Upside: +2.48%
Avantor
Jul 8, 2026
Reiterated: Hold
Price Target: $9 → $11
Current: $16.29
Upside: -32.47%
Charles River Laboratories International
Jul 8, 2026
Reiterated: Buy
Price Target: $265
Current: $300.02
Upside: -11.67%
Guardant Health
Jul 8, 2026
Reiterated: Buy
Price Target: $150 → $215
Current: $157.88
Upside: +36.18%
Mettler-Toledo International
Jul 8, 2026
Reiterated: Buy
Price Target: $1,550
Current: $1,625.73
Upside: -4.66%
Jul 8, 2026
Reiterated: Hold
Price Target: $13 → $18
Current: $12.76
Upside: +41.07%
Jul 8, 2026
Reiterated: Hold
Price Target: $24 → $45
Current: $69.89
Upside: -35.61%
Jun 29, 2026
Downgraded: Hold
Price Target: $70 → $73
Current: $72.49
Upside: +0.70%
May 29, 2026
Reiterated: Hold
Price Target: $120 → $140
Current: $168.18
Upside: -16.76%
May 28, 2026
Reiterated: Buy
Price Target: $23
Current: $17.64
Upside: +30.39%
May 8, 2026
Reiterated: Buy
Price Target: $35 → $28
Current: $30.71
Upside: -8.82%
May 6, 2026
Reiterated: Buy
Price Target: $60 → $55
Current: $35.19
Upside: +56.29%
Apr 29, 2026
Reiterated: Hold
Price Target: $55 → $38
Current: $46.55
Upside: -18.37%
Apr 24, 2026
Reiterated: Buy
Price Target: $375 → $400
Current: $383.91
Upside: +4.19%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $352.82
Upside: -14.97%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $265.88
Upside: -24.78%
Apr 7, 2026
Reiterated: Buy
Price Target: $26
Current: $19.02
Upside: +36.70%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $434.27
Upside: -2.13%
Apr 6, 2026
Reiterated: Buy
Price Target: $685
Current: $679.38
Upside: +0.83%
Feb 11, 2026
Reiterated: Hold
Price Target: $215
Current: $234.91
Upside: -8.48%
Jan 2, 2026
Reiterated: Buy
Price Target: $325
Current: $318.83
Upside: +1.94%
May 22, 2025
Reiterated: Buy
Price Target: $135
Current: $150.94
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $9 → $6
Current: $3.68
Upside: n/a
Mar 23, 2023
Reiterated: Hold
Price Target: $1.5 → $4.25
Current: $2.03
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $62
Current: $24.19
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $6
Current: $15.88
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $32 → $36
Current: $23.95
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $4.21
Upside: n/a
Nov 30, 2018
Reiterated: Hold
Price Target: $4.5
Current: $0.0007
Upside: n/a